SynthesisBMC cancer2026

Immunotherapy combined with chemotherapy as first-line treatment for HER2-negative advanced gastric or gastroesophageal junction cancer: systematic review and Bayesian network meta-analysis based on specific PD-L1 expression levels.

Wen Yi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.